APA (7th ed.) Citation

T, M., M, A., K, O., K, O., M, S., M, M., . . . Y, M. (2026). SGLT2 inhibitor requires co-administration with diuretics to effectively reduce interstitial fluid retention: The DAPA-BODY trial. Hypertension research : official journal of the Japanese Society of Hypertension, 49(2), 499. https://doi.org/10.1038/s41440-025-02388-5

Chicago Style (17th ed.) Citation

T, Masuda, et al. "SGLT2 Inhibitor Requires Co-administration with Diuretics to Effectively Reduce Interstitial Fluid Retention: The DAPA-BODY Trial." Hypertension Research : Official Journal of the Japanese Society of Hypertension 49, no. 2 (2026): 499. https://doi.org/10.1038/s41440-025-02388-5.

MLA (9th ed.) Citation

T, Masuda, et al. "SGLT2 Inhibitor Requires Co-administration with Diuretics to Effectively Reduce Interstitial Fluid Retention: The DAPA-BODY Trial." Hypertension Research : Official Journal of the Japanese Society of Hypertension, vol. 49, no. 2, 2026, p. 499, https://doi.org/10.1038/s41440-025-02388-5.